Global smart speaker market was valued at $14.8 billion in 2025 and is growing at a CAGR of 19.5 % during the forecast period (2026-2035). Wi-Fi enables smart speakers to connect to home networks, allowing high-quality streaming from multiple services, multi-room audio synchronization, and integration with smart home ecosystems. Advanced standards like Wi-Fi 6/6e improve speed, stability, and low-latency performance, enhancing overall user experience and supporting seamless wireless audio throughout the home.

Rechargeable battery market size is anticipated to reach $354.1 billion by 2035 and is projected to grow at a CAGR of 10.2% from 2026 to 2035, according to a new report by Orion Market Research Pvt. Ltd. for instance, in March 2025, Toshiba introduced its SCiB rechargeable lithium-ion battery in Bangkok, emphasizing its long lifespan and intrinsic safety, critical for electric motorcycle taxis. The battery aims to enhance safety and reliability, supporting Thailand's goal of carbon neutrality by 2050.

Nickel-Cadmium Battery market size is anticipated to reach $232.4 million by 2035 and is projected to grow at a CAGR of 7.5% from 2025 to 2035, according to a new report by Orion Market Research Pvt. Ltd. Ni-Cd batteries provide a longer operational life than lead-acid batteries, making them ideal for applications requiring long-term reliability, which is a key driver of market growth. This reliability and durability have prompted utility companies to adopt Ni-Cd solutions for essential infrastructure. For instance, in February 2025, Power Grid Corp. of India Ltd (PGCIL) partnered with Volks Energie to implement nickel-cadmium battery solutions at its substations.

Nano Battery market size is anticipated to reach $67.0 million by 2035 and is projected to grow at a CAGR of 18.5% from 2026 to 2035, according to a new report by Orion Market Research Pvt. Ltd. Technological advancements in battery materials, particularly in lithium iron phosphate (LFP) and nano-scale cathode materials, are improving energy density, safety, and lifecycle, thereby driving market growth in automotive and grid applications. Such developments are further supported by government funding and investments aimed at scaling production capacities to meet growing demand.

Biometric systems market size is anticipated to reach $169.4 billion by 2035 and is projected to grow at a CAGR of 12.2% from 2026 to 2035, according to a new report by Orion Market Research Pvt. Ltd. Fingerprint recognition is a widely used biometric technology that identifies individuals based on unique patterns of ridges and valleys on their fingers. It provides secure, reliable authentication for access control, digital transactions, and identity verification across sectors such as banking, healthcare, government, and travel. Its accuracy, ease of use, and integration flexibility make it a foundational component of modern biometric systems.

Global melanoma cancer market was valued at $10.5 billion in 2025 and is growing at a CAGR of 10.1% during the forecast period (2026-2035). Regulatory support, including accelerated approval pathways and priority review mechanisms for advanced oncology indications, plays a crucial role in promoting innovation and facilitating the timely market entry of novel melanoma therapies. These frameworks aim to address high unmet needs in patients with advanced or treatment-resistant disease, where conventional therapeutic options offer limited clinical benefit.

High-Performance Liquid Chromatography (HPLC) market was valued at $5,572.7 million in 2025 and is projected to reach $8,360.3 million by 2035, growing at a CAGR of 4.2% during the forecast period (2026-2035). Recent technological advancements in the high-performance liquid chromatography (HPLC) market are centered on improving analytical performance, throughput, and ease of use. Manufacturers have introduced ultra-high-pressure liquid chromatography (UHPLC) systems capable of faster separations with higher resolution and lower solvent consumption compared with traditional HPLC platforms. New column chemistries, such as core-shell and superficially porous particles, are enhancing peak capacity and sensitivity for complex sample matrices across pharmaceutical, environmental, and food testing labs. Several companies have also launched next-generation detectors, including multi-wavelength UV, charged aerosol, and mass spectrometry-compatible interfaces, to broaden the range of detectable analytes and improve quantitative accuracy.

Osteoarthritis Therapeutics market was valued at $11,200.0 million in 2025 and is projected to reach $24,744.3 million by 2035, growing at a CAGR of 8.2% during the forecast period (2026-2035). The growing burden of arthritis-related disability is a critical driver shaping demand in the osteoarthritis therapeutics market, as functional impairment significantly increases the need for sustained medical intervention. According to US Centers for Disease Control and Prevention, an estimated 58.5 million adults aged 18 years and older in the US have arthritis, underscoring the scale of the affected population. Of these individuals, 25.7 million report arthritis-attributable activity limitations, reflecting substantial disease impact on daily functioning and quality of life. Projections further indicate that by 2040, approximately 34.6 million adults with arthritis are expected to experience activity limitations, indicating a worsening disability burden over time.

European osteoarthritis therapeutics market was valued at $3,304.0 million in 2025 and is projected to reach $7,052.1 million by 2035, growing at a CAGR of 8.2% during the forecast period (2026–2035). Increased regulatory approvals of osteoarthritis therapies by European manufacturers are a key driver for growth in the market, as locally developed drugs expand treatment availability and reinforce clinician confidence in therapeutic intervention. European pharmaceutical firms are actively advancing product portfolios through new molecule approvals and expanded indications, with regulatory oversight by the European Medicines Agency (EMA) ensuring safety and efficacy across member states. This environment has supported approvals of both traditional symptom-relief drugs and newer intra-articular therapies, helping widen patient access to effective treatment options.

European High-Performance Liquid Chromatography (HPLC) market was valued at $1,696.8 million in 2025 and is projected to reach $2462.1 million by 2035, growing at a CAGR of 4.2% during the forecast period (2026-2035). Expanding pharmaceutical manufacturing and stringent quality control requirements in Europe are key drivers for this market in the region. The European Medicines Agency (EMA) and national competent authorities enforce rigorous Good Manufacturing Practice (GMP) standards to ensure that pharmaceutical products consistently meet predefined quality, safety, and efficacy criteria before they reach patients.